Financhill
Sell
45

CNR.TO Quote, Financials, Valuation and Earnings

Last price:
$135.38
Seasonality move :
2.93%
Day range:
$135.15 - $136.70
52-week range:
$126.11 - $154.56
Dividend yield:
2.58%
P/E ratio:
18.49x
P/S ratio:
4.97x
P/B ratio:
3.94x
Volume:
1.3M
Avg. volume:
1.4M
1-year change:
-10.02%
Market cap:
$83.8B
Revenue:
$17B
EPS (TTM):
$7.36

Earnings Data

Next earnings date for CNR.TO
Jan 27
2026
Most recent earnings per share
$1.83
Beat by $0.06
(Oct 31/2025)
Consensus Estimate
$1.77
(Oct 31/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

CNR.TO Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
01/27/2026 Q4 $4.4B -- -- $1.97 --
10/31/2025 Q3 $4.2B $4.2B $1.83 $1.77 $0.06
07/22/2025 Q2 $4.3B $4.3B $1.87 $1.87 -$0.01
05/01/2025 Q1 $4.4B $4.4B $1.85 $1.78 $0.07
01/30/2025 Q4 $4.4B $4.4B $1.82 $1.93 -$0.11
10/22/2024 Q3 $4.1B $4.1B $1.72 $1.70 $0.02
07/23/2024 Q2 $4.4B $4.3B $1.75 $1.93 -$0.18
04/23/2024 Q1 $4.3B $4.2B $1.72 $1.72 -$0.00
01/23/2024 Q4 $4.4B $4.5B $3.29 $1.98 $1.31
10/24/2023 Q3 $4.1B $4B $1.69 $1.72 -$0.03
07/25/2023 Q2 -- $4.1B $1.76 -- --
04/24/2023 Q1 -- $4.3B $1.82 -- --
01/24/2023 Q4 -- $4.5B $2.10 -- --
10/25/2022 Q3 -- $4.5B $2.13 -- --
07/26/2022 Q2 -- $4.3B $1.92 -- --
04/25/2022 Q1 -- $3.7B $1.31 -- --
01/25/2022 Q4 -- $3.8B $1.70 -- --
10/19/2021 Q3 -- $3.6B $2.37 -- --
07/20/2021 Q2 -- $3.6B $1.46 -- --
04/26/2021 Q1 -- $3.5B $1.37 -- --
01/26/2021 Q4 -- $3.7B $1.43 -- --
10/20/2020 Q3 -- $3.4B $1.38 -- --
07/21/2020 Q2 -- $3.2B $0.77 -- --
04/27/2020 Q1 -- $3.5B $1.42 -- --
01/28/2020 Q4 -- $3.6B $1.22 -- --
10/22/2019 Q3 -- $3.8B $1.66 -- --
07/23/2019 Q2 -- $4B $1.88 -- --
04/29/2019 Q1 -- $3.5B $1.08 -- --
01/29/2019 Q4 -- $3.8B $1.56 -- --
10/23/2018 Q3 -- $3.7B $1.54 -- --
07/24/2018 Q2 -- $3.6B $1.77 -- --
04/23/2018 Q1 -- $3.2B $1.00 -- --
01/23/2018 Q4 -- $3.3B $3.48 -- --
10/24/2017 Q3 -- $3.2B $1.27 -- --
07/25/2017 Q2 -- $3.3B $1.36 -- --
04/24/2017 Q1 -- $3.2B $1.16 -- --
01/24/2017 Q4 -- $3.2B $1.32 -- --
10/25/2016 Q3 -- $3B $1.25 -- --
07/25/2016 Q2 -- $2.8B $1.10 -- --
04/25/2016 Q1 -- $3B $1.00 -- --
01/26/2016 Q4 -- $3.2B $1.18 -- --

Canadian National Railway Co. Earnings Questions

  • How Much did Canadian National Railway Co. Generate in Revenue Last Quarter?

    Canadian National Railway Co. reported $4.2B worth of top line sales in its most recent quarter.

  • Did Canadian National Railway Co. Beat Earnings Last Quarter?

    Canadian National Railway Co. announced earnings per share of $1.83 which represents a beat of analyst forecast a $1.77 per share.

  • Is Canadian National Railway Co. Profitable?

    Canadian National Railway Co. reported $1.9B that represents $3.00 per share over the last quarter.

  • What is the Analyst Consensus for Canadian National Railway Co. EPS Next Year?

    Canadian National Railway Co.'s earnings are forecast to grow from $7.01 per share to $7.22 per share next year representing an increase of 7.14%.

  • When is Canadian National Railway Co.'s Earnings Date?

    Canadian National Railway Co.'s next earnings date is January 27, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Did Netflix Buy Warner Bros?
Why Did Netflix Buy Warner Bros?

Following a bidding war, Netflix (NASDAQ:NFLX) has announced its intention…

Why Did SoFi Stock Drop?
Why Did SoFi Stock Drop?

Fintech platform SoFi (NASDAQ:SOFI) has stumbled in recent days, selling…

Will Robinhood Win AI Investing?
Will Robinhood Win AI Investing?

Recently, online brokerage Robinhood (NASDAQ:HOOD) has been focused on introducing…

Stock Ideas

Buy
64
Is NVDA Stock a Buy?

Market Cap: $4.5T
P/E Ratio: 63x

Buy
56
Is AAPL Stock a Buy?

Market Cap: $4.1T
P/E Ratio: 37x

Buy
59
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Buy
67
GPCR alert for Dec 9

Structure Therapeutics, Inc. [GPCR] is down 4.73% over the past day.

Buy
62
SMX alert for Dec 9

SMX (Security Matters) Plc [SMX] is up 7.57% over the past day.

Buy
90
KYMR alert for Dec 9

Kymera Therapeutics, Inc. [KYMR] is down 7.87% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock